InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Blackwell Kimberly, Director. Director active across 1 company, notably Zentalis Pharmaceuticals, Inc.. Cumulatively, 8 filings have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €48k. History available since 4 June 2021. The latest transaction was disclosed on 1 February 2024 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Blackwell Kimberly
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
250,000 shares0Common StockSEC:0001725160-24-000026:0
5,000 shares@ US$10.289612.6% of flowCommon StockSEC:0001725160-23-000200:0
Canonical exit: 11 Feb 2024 (T+90)
244,800 shares0Common StockSEC:0001725160-23-000018:0
1,000 shares@ US$47.8019.6% of flowCommon StockSEC:0001725160-22-000005:0
1,000 shares@ US$47.8019.6% of flowCommon StockSEC:0001725160-21-000231:0
1,000 shares@ US$47.8019.2% of flowCommon StockSEC:0001725160-21-000210:0
1,000 shares@ US$47.8019.2% of flowCommon StockSEC:0001725160-21-000207:0
5,000 shares0Common StockSEC:0001725160-21-000143:0
8 of 8 declarations
About Blackwell Kimberly
Kimberly Blackwell is a Board Member at Zentalis Pharmaceuticals, Inc. As a board member, she participates in the governance and strategy of the company. Her experience is an asset for the organization's development.
